Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2018American Journal of HematologyOpen Access

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMaria GilleeceMLMyriam LabopinIYIbrahim Yakoub‐Agha

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gilleece et al. (2018) studied this question.

synapsesocial.com/papers/6a110de1e45452a730f331f0https://doi.org/10.1002/ajh.25211
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype2005 · 1,920 citations
  2. 2Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome2010 · 339 citations
  3. 3Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial2015 · 175 citations
  4. 4How I monitor residual disease in chronic myeloid leukemia2009 · 51 citations
  5. 5Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia2016 · 68 citations